Ken L Chambliss Selected Research

Ken L Chambliss Research Topics

Disease

4	Obesity 12/2019 - 08/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 02/2008
4	Breast Neoplasms (Breast Cancer) 11/2018 - 07/2010
3	Atherosclerosis 01/2019 - 10/2002
3	Neoplasms (Cancer) 11/2018 - 08/2014
3	Insulin Resistance 01/2018 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2016 - 06/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 10/2018
2	Hypertension (High Blood Pressure) 12/2019 - 02/2015
2	Infarction (Infarctions) 11/2018 - 01/2017
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Myocardial Infarction 01/2019
1	Neuroinflammatory Diseases 11/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2018
1	Stroke (Strokes) 11/2018
1	Thrombosis (Thrombus) 10/2018
1	Weight Gain 01/2018
1	Reperfusion Injury 01/2017
1	Body Weight (Weight, Body) 08/2014
1	Fatty Liver 08/2014
1	Endometrial Neoplasms (Endometrial Cancer) 07/2010
1	Hyperplasia 07/2010
1	Electric Injuries 01/2006
1	Vascular Diseases (Vascular Disease) 01/2006
1	Vascular System Injuries 10/2002

Drug/Important Bio-Agent (IBA)

4	Estrogens (Estrogen)FDA Link 11/2018 - 10/2002
4	Estradiol (Delestrogen)FDA LinkGeneric 11/2018 - 07/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2014
4	C-Reactive ProteinIBA 01/2016 - 06/2009
3	IgG Receptors (Fc gamma RI)IBA 12/2019 - 02/2015
3	Immunoglobulin G (IgG)IBA 12/2019 - 02/2015
3	Insulin (Novolin)FDA Link 01/2018 - 06/2009
2	N-acetylmannosamineIBA 12/2019 - 01/2018
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2019 - 01/2018
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 02/2008
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2018 - 01/2016
2	Estrogen Receptor alphaIBA 01/2017 - 07/2010
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2015 - 02/2008
2	HDL CholesterolIBA 02/2008 - 01/2006
2	HDL LipoproteinsIBA 02/2008 - 01/2006
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Estrogen ReceptorsIBA 11/2018
1	(S)- 5- (4- hydroxy- 3,5- dimethyl- phenyl)- indan- 1- olIBA 11/2018
1	low density lipoprotein receptor-related protein 8IBA 10/2018
1	Antiphospholipid AntibodiesIBA 10/2018
1	Glycoproteins (Glycoprotein)IBA 10/2018
1	LigandsIBA 01/2018
1	AminesIBA 10/2016
1	Apolipoproteins E (ApoE)IBA 10/2016
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 10/2016
1	Dendrimers (Dendrons)IBA 10/2016
1	Serum Amyloid P-ComponentIBA 02/2015
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2014
1	bazedoxifeneIBA 08/2014
1	SteroidsIBA 08/2014
1	Conjugated (USP) Estrogens (Premarin)FDA Link 08/2014
1	GTP-Binding Proteins (G-Protein)IBA 07/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2009
1	high density lipoprotein receptorsIBA 02/2008
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2006

Therapy/Procedure

1	Therapeutics 10/2016